“…Hospitalization, medications, and underlying diseases are considered to increase the incidence of EDTA-PTCP [1,20]. For instance, EDTA-PTCP has been documented in patients with a wide variety of disorders, including autoimmune disease [15], viral [21] and bacterial infection, chronic liver diseases [15], metabolic syndromes, malignancies [15,22], and even in patients undergoing allogeneic stem cell transplantation [23].…”